Skip to main content
Journal cover image

AT-48 * A PHASE 1 TRIAL OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) IN COMBINATION WITH BEVACIZUMAB FOR ADULT PATIENTS WITH RECURRENT MALIGNANT GLIOMA POST-BEVACIZUMAB FAILURE

Publication ,  Journal Article
Ranjan, T; Peters, KB; Vlahovic, G; Watts, J; Dutton, S; Boulton, S; Lipp, E; Herndon, J; Healy, P; Miller, E; Friedman, H; Karmali, R; Desjardins, A
Published in: Neuro-Oncology
November 1, 2014

Duke Scholars

Published In

Neuro-Oncology

DOI

EISSN

1523-5866

ISSN

1522-8517

Publication Date

November 1, 2014

Volume

16

Issue

suppl 5

Start / End Page

v19 / v19

Publisher

Oxford University Press (OUP)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ranjan, T., Peters, K. B., Vlahovic, G., Watts, J., Dutton, S., Boulton, S., … Desjardins, A. (2014). AT-48 * A PHASE 1 TRIAL OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) IN COMBINATION WITH BEVACIZUMAB FOR ADULT PATIENTS WITH RECURRENT MALIGNANT GLIOMA POST-BEVACIZUMAB FAILURE. Neuro-Oncology, 16(suppl 5), v19–v19. https://doi.org/10.1093/neuonc/nou237.47
Ranjan, T., K. B. Peters, G. Vlahovic, J. Watts, S. Dutton, S. Boulton, E. Lipp, et al. “AT-48 * A PHASE 1 TRIAL OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) IN COMBINATION WITH BEVACIZUMAB FOR ADULT PATIENTS WITH RECURRENT MALIGNANT GLIOMA POST-BEVACIZUMAB FAILURE.” Neuro-Oncology 16, no. suppl 5 (November 1, 2014): v19–v19. https://doi.org/10.1093/neuonc/nou237.47.
Ranjan T, Peters KB, Vlahovic G, Watts J, Dutton S, Boulton S, et al. AT-48 * A PHASE 1 TRIAL OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) IN COMBINATION WITH BEVACIZUMAB FOR ADULT PATIENTS WITH RECURRENT MALIGNANT GLIOMA POST-BEVACIZUMAB FAILURE. Neuro-Oncology. 2014 Nov 1;16(suppl 5):v19–v19.
Ranjan, T., et al. “AT-48 * A PHASE 1 TRIAL OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) IN COMBINATION WITH BEVACIZUMAB FOR ADULT PATIENTS WITH RECURRENT MALIGNANT GLIOMA POST-BEVACIZUMAB FAILURE.” Neuro-Oncology, vol. 16, no. suppl 5, Oxford University Press (OUP), Nov. 2014, pp. v19–v19. Crossref, doi:10.1093/neuonc/nou237.47.
Ranjan T, Peters KB, Vlahovic G, Watts J, Dutton S, Boulton S, Lipp E, Herndon J, Healy P, Miller E, Friedman H, Karmali R, Desjardins A. AT-48 * A PHASE 1 TRIAL OF CARBOXYAMIDOTRIAZOLE OROTATE (CTO) IN COMBINATION WITH BEVACIZUMAB FOR ADULT PATIENTS WITH RECURRENT MALIGNANT GLIOMA POST-BEVACIZUMAB FAILURE. Neuro-Oncology. Oxford University Press (OUP); 2014 Nov 1;16(suppl 5):v19–v19.
Journal cover image

Published In

Neuro-Oncology

DOI

EISSN

1523-5866

ISSN

1522-8517

Publication Date

November 1, 2014

Volume

16

Issue

suppl 5

Start / End Page

v19 / v19

Publisher

Oxford University Press (OUP)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences